LBA83 PECATI: A phase II trial to evaluate the efficacy and safety of lenvatinib in combination with pembrolizumab in pretreated advanced B3-thymoma and thymic carcinoma
J. Remon Masip, Paolo Bironzo, N. Girard, L. Bigay-Game et autres
fr, it, es (code pays fourni par la source)